Study Title: Phase Ib/II Study of Concurrent Durvalumab And Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Patients with Urothelial Cancer (T2-4 N0-2 M0) of the Bladder
 

  • Status: Completed

Study Contact: studies@hoosiercancer.org; (317) 921-2050.